Reality of MedTech In 2025

• ​Gain insights into the most common pitfalls MedTech companies face and how to avoid them.
• ​Learn strategies for scaling and sustaining success in the MedTech space.
• ​Engage in meaningful discussions with industry leaders and peers.

• ​ is a corporate and securities partner at Wilson Sonsini's San Francisco office, where he leads one of the nation’s most active practices representing venture-backed companies. He advises life sciences and technology companies on corporate matters, mergers and acquisitions, IPOs, strategic partnerships, and private equity and debt financings. In addition to working with companies, James represents venture capital firms and other investors in financing transactions. He also serves on the investment committee for the firm’s affiliated fund, the WS Investment Company.
• ​ is the founder and CEO of NasalAid. A medical device company focused on improving nasal breathing. She is a Silicon Valley native and the daughter of two inventors. She has spent the last 10 years in medtech and has helped millions of patients breathe better.
• ​ is a seasoned leader and regulatory expert who helps companies get medical devices and combination products to market. David has served in senior leadership roles at AscentX Medical and ConvaTec, and previously worked at the U.S. Food and Drug Administration (FDA), and St. Jude Medical. He is a founding member of the Kidney Health Initiative, and has helped several startups acquire funding and successfully interact with FDA and the Department of Defense. While at FDA, David worked on DARPA projects and consulted with CBER and CDER regarding regulatory submissions, including clinical studies and drug and biologic marketing submissions.

​Don’t miss this chance to gain insider knowledge and connect with the MedTech community as we look ahead to 2025 and beyond!

Host or Publisher Life Science Entrepreneurs